全食物植物性强化生活方式干预改善2型糖尿病患者的血糖控制并减少用药:一项随机对照试验
在169名马绍尔群岛2型糖尿病成人中开展的平行臂随机对照试验显示,与标准医疗相比,全食物植物性饮食联合适度运动的强化干预在第12周和第24周分别额外降低HbA1c 14 mmol/mol(1.3%)和8 mmol/mol(0.7%),并减少降糖药和心血管药物使用,部分患者实现糖尿病缓解。
要点
- 第12周时,植物性饮食+运动组HbA1c降低22 mmol/mol,标准医疗组降低7 mmol/mol,组间差异14 mmol/mol(p<0.0001)。
- 第24周时,植物性饮食+运动组HbA1c降低16 mmol/mol,标准医疗组降低8 mmol/mol,组间差异8 mmol/mol(p=0.01)。
- 接受药物治疗的植物性饮食+运动组中63%减少降糖药,标准医疗组为24%(p=0.006)。
核心结论
- 全食物植物性生活方式干预在改善血糖控制方面比标准医疗更有效。
- 该干预还减少了糖尿病和心血管药物的需求,并使部分参与者实现糖尿病缓解。
- 作者认为,这是2型糖尿病患者一种有效的、基于证据的生活方式选择。
研究设计与样本
- 在2型糖尿病成人中开展的平行臂随机对照试验,采用计算机1:1随机化。
- 共随机169名18-75岁马绍尔群岛2型糖尿病成人,分配至全食物植物性干预联合适度运动组(PB+Ex,n=79随机)或标准医疗组(SMC,n=90随机)。
- PB+Ex干预包括12周的餐食、运动课程和小组课程,干预期24周。
- 仅实验室分析人员设盲。
主要发现
- 与SMC组(n=90随机,n=70分析)相比,PB+Ex组(n=79随机,n=66分析)第12周HbA1c额外降低14 mmol/mol(1.3%):PB+Ex组降低22 mmol/mol(2.0%),SMC组降低7 mmol/mol(0.7%),p<0.0001。
- 第24周HbA1c额外降低8 mmol/mol(0.7%):PB+Ex组降低16 mmol/mol(1.4%),SMC组降低8 mmol/mol(0.7%),p=0.01。
- 接受药物治疗的PB+Ex参与者中63%减少降糖药物,SMC组为24%(p=0.006)。
- 基线HbA1c<75 mmol/mol(<9%)的PB+Ex参与者中23%实现缓解。
- 与SMC相比,PB+Ex干预还降低体重(-2.7 kg;p<0.0001)、C反应蛋白(-11 nmol/l;p=0.005)和心血管药物使用。
临床怎么用
- 作者认为,全食物植物性生活方式干预是2型糖尿病患者一种有效的、基于证据的生活方式选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We conducted the largest and longest clinical trial comparing a whole-food, plant-based intervention with standard medical care (SMC) in individuals with type 2 diabetes. METHODS: We randomised (parallel-arm; computerised 1:1 randomisation ratio) 169 adults aged 18-75 years with type 2 diabetes in the Marshall Islands to an intensive whole-food, plant-based intervention with moderate exercise (PB+Ex) or SMC for 24 weeks. The PB+Ex intervention included 12 weeks of meals, exercise sessions and group classes. Primary outcomes were glycaemic control (HbA1c, glucose, insulin and HOMA-IR) and glucose-lowering medication use. Secondary outcomes included lipids, blood pressure, heart rate and C-reactive protein. Only lab analysts were blinded. RESULTS: Compared with SMC (n=90 randomised; n=70 analysed), the PB+Ex (n=79 randomised; n=66 analysed) intervention decreased HbA1c by an additional 14 mmol/mol (1.3%) at week 12 (-22 vs -7 mmol/mol [-2.0% vs -0.7%]; p<0.0001) and 8 mmol/mol (0.7%) at week 24 (-16 vs -8 mmol/mol [-1.4% vs -0.7%]; p=0.01). Concomitantly, 63% of medicated PB+Ex participants reduced their glucose-lowering medications (vs 24%; p=0.006), and 23% of PB+Ex participants with a baseline HbA1c <75 mmol/mol (<9%) achieved remission. Additionally, the PB+Ex intervention reduced weight (-2.7 kg; p<0.0001), C-reactive protein (-11 nmol/l; p=0.005) and cardiovascular medication use compared with SMC. At intermediate timepoints, it improved glucose, insulin, HOMA-IR, cholesterol, triglycerides and heart rate, but not at week 24. CONCLUSIONS/INTERPRETATION: A whole-food, plant-based lifestyle intervention was more effective for improving glycaemic control than SMC. It also reduced the need for diabetes and cardiovascular medications and induced diabetes remission in some participants. Therefore, it is an effective, evidence-based lifestyle option for individuals with type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03862963 FUNDING: This research was funded by the Department of the Army (W81XWH-05-1-0547). CJH received support through a National Institutes of Health Predoctoral T32 Obesity Fellowship (T32 HL105349).
引用
- Hanick CJ, Peterson CM, Davis BC, et al. A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2024. PMID: 39305340. doi:10.1007/s00125-024-06272-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。